Nervous System Stem Cells Research Center, Semnan University of Medical Sciences, Semnan, Iran.
Department of Tissue Engineering and Applied Cell Sciences, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran.
Skin Res Technol. 2024 Sep;30(9):e70016. doi: 10.1111/srt.70016.
Tissue engineering and regenerative medicine (TERM) aim to repair or replace damaged or lost tissues or organs due to accidents, diseases, or aging, by applying different sciences. For this purpose, an essential part of TERM is the designing, manufacturing, and evaluating of scaffolds, cells, tissues, and organs. Artificial intelligence (AI) or the intelligence of machines or software can be effective in all areas where computers play a role.
The "artificial intelligence," "machine learning," "tissue engineering," "clinical evaluation," and "scaffold" keywords used for searching in various databases and articles published from 2000 to 2024 were evaluated.
The combination of tissue engineering and AI has created a new generation of technological advancement in the biomedical industry. Experience in TERM has been refined using advanced design and manufacturing techniques. Advances in AI, particularly deep learning, offer an opportunity to improve scientific understanding and clinical outcomes in TERM.
The findings of this research show the high potential of AI, machine learning, and robots in the selection, design, and fabrication of scaffolds, cells, tissues, or organs, and their analysis, characterization, and evaluation after their implantation. AI can be a tool to accelerate the introduction of tissue engineering products to the bedside.
The capabilities of artificial intelligence (AI) can be used in different ways in all the different stages of TERM and not only solve the existing limitations, but also accelerate the processes, increase efficiency and precision, reduce costs, and complications after transplantation. ML predicts which technologies have the most efficient and easiest path to enter the market and clinic. The use of AI along with these imaging techniques can lead to the improvement of diagnostic information, the reduction of operator errors when reading images, and the improvement of image analysis (such as classification, localization, regression, and segmentation).
组织工程和再生医学(TERM)旨在通过应用不同的科学来修复或替换因事故、疾病或衰老而受损或丢失的组织或器官。为此,TERM 的一个重要部分是支架、细胞、组织和器官的设计、制造和评估。人工智能(AI)或机器或软件的智能可以在计算机发挥作用的所有领域都发挥作用。
在各种数据库和 2000 年至 2024 年期间发表的文章中,使用“人工智能”、“机器学习”、“组织工程”、“临床评估”和“支架”等关键词进行了搜索和评估。
组织工程和 AI 的结合为生物医学产业创造了新一代技术进步。先进的设计和制造技术使 TERM 的经验得到了改进。人工智能,特别是深度学习的进步,为提高 TERM 中的科学理解和临床结果提供了机会。
这项研究的结果表明,人工智能、机器学习和机器人在支架、细胞、组织或器官的选择、设计和制造及其植入后的分析、特征描述和评估方面具有很高的潜力。人工智能可以作为一种工具,加速组织工程产品向临床的引入。
人工智能(AI)的功能可以在 TERM 的所有不同阶段以不同的方式使用,不仅可以解决现有局限性,还可以加速这些过程,提高效率和精度,降低成本,并减少移植后的并发症。机器学习预测哪些技术最有希望以最高效和最简单的途径进入市场和临床。人工智能与这些成像技术的结合可以提高诊断信息,减少操作人员读取图像时的错误,并改善图像分析(如分类、定位、回归和分割)。